Purple Biotech (PPBT) Non Operating Income (2014 - 2026)
Purple Biotech (PPBT) reported Non Operating Income of -$2.2 million for Q1 2026, down 127.58% year-over-year from $7.8 million in Q1 2025, and down 127.58% on a QoQ basis from -$950000.0 in Q1 2025.
Purple Biotech (PPBT) has 2 years of Non Operating Income data on file, last reported at -$2.2 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | -2.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.16 Mn |
| Dec 31, 2025 | 197,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Mar 31, 2025 | -950,000.00 |
| Dec 31, 2024 | -601,000.00 |
| Sep 30, 2024 | -1.47 Mn |
| Mar 31, 2024 | -685,000.00 |
| Dec 31, 2023 | -1.41 Mn |
| Sep 30, 2023 | -692,000.00 |
| Mar 31, 2023 | -219,000.00 |
| Dec 31, 2022 | -558,000.00 |
| Sep 30, 2022 | -232,000.00 |
| Jun 30, 2022 | -38,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | -47,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | -98,000.00 |
| Dec 31, 2019 | -522,000.00 |
| Dec 31, 2018 | -3.07 Mn |
| Dec 31, 2015 | 15,000.00 |
| Dec 31, 2014 | -75,000.00 |